跳至主要内容
临床试验/CTRI/2018/08/015400
CTRI/2018/08/015400尚未招募2 期

Clinical Validation of Unani Pharmacopoeal formulation Safoof e Teen in Zaheer (Dysentery)

Central Council For Research In Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of either sex in the age group 18-65 years.
  • 2. Patients of ZahÄ«r (Dysentery) having the following signs and symptoms:
  • (i) 2-8 small-volume, semiformed or unformed stools/day
  • (ii) BarÄ?z DamwÄ« (Bloody Stools) and/or BarÄ?z MukhÄ?tÄ« (Mucoid Stools)
  • (iii) E. histolytica Cysts or Trophozoites in stools
  • With or without any of the following:
  • Maghs (Tenesmus)
  • Wajaâ?? al-Batn Asfal (Lower Abdominal Pain)
  • ĪlÄ?m al-Batn Asfal (Lower Abdominal Tenderness)

排除标准

  • 1. Patients having diarrhoea with >8 stools/day
  • 2. Moderate or severe dehydration
  • 3. Fever (>=101 °F)
  • 4. Patients having amoebic dysentery with any associated severe complications, e.g., fulminant colitis with perforation, paralytic ileus, toxic megacolon, ameboma, and liver abscess.
  • 5. Clinical evidence of coexisting acute systemic illnesses
  • 6. History or clinical evidence of chronic diseases requiring long-term treatment, e.g., DM, hypertension, tuberculosis, HIV infection, chronic liver disease, CKD, coeliac disease, IBD, or any other serious and/or unstable medical condition that, in the opinion of the investigator, could constitute a risk when taking study drug or could interfere with the interpretation of data.
  • 7. Pregnant and lactating women
  • 8. H/o Addiction (alcohol, drugs)
  • 9. H/o Hypersensitivity to the study drug or any of its ingredients

研究者

相似试验